Lack of prolonged activity of a new ACTH preparation (DW-75) in human subjects.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000305:Adrenal Cortex Hormones / Q000097:blood; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000138:chemical synthesis / Q000494:pharmacology*; D000595:Amino Acid Sequence; D000818:Animals; D001681:Biological Assay; D002986:Clinical Trials as Topic; D006801:Humans; D007018:Hypopituitarism / Q000097:blood / Q000652:urine; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D010455:Peptides / Q000138:chemical synthesis / Q000494:pharmacology*; D012694:Serine; D013237:Stereoisomerism; D013552:Swine
D015065:17-Hydroxycorticosteroids; D000305:Adrenal Cortex Hormones; D010455:Peptides; D012694:Serine; D000324:Adrenocorticotropic Hormone